Nov 14, 2023 / 05:00PM GMT
Mason Owen Carrico - Stephens Inc., Research Division - Research Analyst
We'll go and get started here. Thanks, everyone, for joining us on Mason care (inaudible), I'm the diagnostics and in genomics analyst at Stephens today. We have Mike Brophy of Natera with us. Mike, thanks for joining us.
Michael B. Brophy - Natera, Inc. - CFO
(inaudible).
Questions and Answers:
Mason Owen Carrico - Stephens Inc., Research Division - Research AnalystIf at any point, anyone in the audience has a question, just feel free to jump in and ask. Maybe we'll kick it off with the quarter. You guys beat on the top line, made additional progress on gross margin had a pretty significant step down in cash burn. You've called out a number of COGS projects in recent quarters. Could you just talk about what has driven the margin improvement recently? What COGS projects are you benefiting from? And maybe what projects are still ahead that could benefit 2024?
Michael B. Brophy - Natera, Inc. - CFO
Trustpilot
